Advertisement

Advertisement

CYYNF Stock Latest News

Cynata Narrows Half-Year Loss but Faces Going Concern Uncertainty

Company AnnouncementsCynata Narrows Half-Year Loss but Faces Going Concern Uncertainty

Cynata to Host Investor Webinar and Expand Online Engagement With Shareholders

PremiumCompany Announcements

Cynata to Host Investor Webinar and Expand Online Engagement With Shareholders

2M ago

Cynata Nears Key Data Readouts as Pivotal Cell Therapy Trials Advance

PremiumCompany Announcements

Cynata Nears Key Data Readouts as Pivotal Cell Therapy Trials Advance

2M ago

Cynata Raises $1.2m via At-The-Market Facility to Support Cell Therapy Pipeline

PremiumCompany Announcements

Cynata Raises $1.2m via At-The-Market Facility to Support Cell Therapy Pipeline

2M ago

Cynata Completes Enrollment in Phase 2 aGvHD Trial

PremiumCompany Announcements

Cynata Completes Enrollment in Phase 2 aGvHD Trial

3M ago

Cynata’s CYP-001 Therapy Shows Promise in Kidney Transplant Trial

PremiumCompany AnnouncementsCynata’s CYP-001 Therapy Shows Promise in Kidney Transplant Trial

4M ago

Cynata Therapeutics Updates Director’s Securities Holdings

Company Announcements

Cynata Therapeutics Updates Director’s Securities Holdings

4M ago

Cynata Therapeutics Announces Change in Director’s Interest

Company Announcements

Cynata Therapeutics Announces Change in Director’s Interest

4M ago

Cynata Therapeutics Announces Change in Director’s Securities Interests

PremiumCompany Announcements

Cynata Therapeutics Announces Change in Director’s Securities Interests

4M ago

Cynata Completes Final Patient Visit in Phase 3 Osteoarthritis Trial

PremiumCompany Announcements

Cynata Completes Final Patient Visit in Phase 3 Osteoarthritis Trial

4M ago

Cynata Therapeutics Unveils Updated Investor Presentation

PremiumCompany Announcements

Cynata Therapeutics Unveils Updated Investor Presentation

4M ago

Cynata Therapeutics Passes Key Resolutions at Annual General Meeting

PremiumCompany Announcements

Cynata Therapeutics Passes Key Resolutions at Annual General Meeting

4M ago

Cynata Therapeutics Hosts Investor Webinar to Update on Key Projects

PremiumCompany AnnouncementsCynata Therapeutics Hosts Investor Webinar to Update on Key Projects

5M ago

Cynata Therapeutics Secures $1.7 Million R&D Tax Refund to Boost Cell Therapy Development

Company Announcements

Cynata Therapeutics Secures $1.7 Million R&D Tax Refund to Boost Cell Therapy Development

5M ago

Cynata Therapeutics Approaches Key Clinical Milestones with Promising Trials

Company Announcements

Cynata Therapeutics Approaches Key Clinical Milestones with Promising Trials

5M ago

Cynata Therapeutics Announces Cessation of Securities

PremiumCompany Announcements

Cynata Therapeutics Announces Cessation of Securities

6M ago

Cynata Therapeutics Announces 2025 AGM Details

PremiumCompany Announcements

Cynata Therapeutics Announces 2025 AGM Details

6M ago

Cynata Therapeutics Schedules AGM and Opens Director Nominations

PremiumCompany Announcements

Cynata Therapeutics Schedules AGM and Opens Director Nominations

6M ago

Cynata Therapeutics Releases Updated Corporate Governance Statement

PremiumCompany Announcements

Cynata Therapeutics Releases Updated Corporate Governance Statement

7M ago

Cynata Therapeutics Advances Clinical Trials Amid Financial Losses

PremiumCompany AnnouncementsCynata Therapeutics Advances Clinical Trials Amid Financial Losses

7M ago

Cynata Therapeutics Issues Shares to Strengthen Financial Position

Company Announcements

Cynata Therapeutics Issues Shares to Strengthen Financial Position

7M ago

Cynata Therapeutics Announces Quotation of New Securities

Company Announcements

Cynata Therapeutics Announces Quotation of New Securities

7M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >